Concepedia

Johan Willemse

JW

Statistics

Publications

11

Citations

292

H-Index

11

Active since

2005

Affiliations

University of Antwerp(Current)

AstraZeneca (Sweden)

Ziekenhuisnetwerk Antwerpen Stuivenberg

ZNA Middelheim Hospital

Johan Willemse is an author at University of Antwerp specializing in biochemistry, life sciences, and enzymology.

Publications per year

2005–2011

11

Publications

11

Limited mutagenesis increases the stability of human carboxypeptidase U (TAFIa) and demonstrates the importance of CPU stability over proCPU concentration in down‐regulating fibrinolysis

Wolfgang Knecht, Johan Willemse, Hanna Stenhamre et al. · FEBS Journal · 2006 · 41 citations

, , +16

The decrease in procarboxypeptidase U (TAFI) concentration in acute ischemic stroke correlates with stroke severity, evolution and outcome

Raf Brouns, Evelien Heylen, Johan Willemse et al. · Journal of Thrombosis and Haemostasis · 2009 · 39 citations · Full text

, , +10

Influence of separator gel in Sarstedt S-Monovette® serum tubes on various therapeutic drugs, hormones, and proteins

Sofie Schouwers, Inger Brandt, Johan Willemse et al. · Clinica Chimica Acta · 2011 · 35 citations

, , +6

Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients

Raf Brouns, Evelien Heylen, Rishi Sheorajpanday et al. · Clinical Neurology and Neurosurgery · 2008 · 31 citations

, , +14

Development of a fast kinetic method for the determination of carboxypeptidase U (TAFIa) using C-terminal arginine containing peptides as substrate

Johan Willemse, Judith Leurs, Robert Verkerk et al. · Analytical Biochemistry · 2005 · 30 citations

, , +9

1–5 of 11